Naidoo, D., Govender, K., & Mantell, J. E. (2024). Breaking barriers: why including boys and men is key to HPV prevention. BMC Medicine, 22(1). https://doi.org/10.1186/s12916-024-03701-8

Agudelo, M. C., Torres-González, E., Agudelo, S., Ramírez, A. T., Castañeda, K. M., Kinslow, C. J., Rodríguez-Herrera, M., Garland, L., Xie, Y., Orozco, C. A., Stoler, M., Dean, M., & Sánchez, G. I. (2024). Comparación de las pruebas para el virus del papiloma humano Hybribio-H13 y Hybrid Capture® 2 para la detección de NIC2+ y NIC3+. Biomédica, 44(Sp. 1), 101–109. https://doi.org/10.7705/biomedica.7061

Denny, L., Saidu, R., Boa, R., Mbatani, N., Castor, D., Moodley, J., & Kuhn, L. (2023). Point-of-care testing with Xpert HPV for single-visit, screen-and-treat for cervical cancer prevention: a demonstration study in South Africa. Scientific Reports, 13(1). https://doi.org/10.1038/s41598-023-43467-2

Connelly, C. F., Collins, N., Cimic, A., & Baskota, S. U. (2023). Significance of concurrent HPV testing with unsatisfactory Papanicolaou test for prediction of follow-up HPV, Papanicolaou test, and biopsy results. American Journal of Clinical Pathology, 160(5), 444–449. https://doi.org/10.1093/ajcp/aqad070

Kulkarni, A., Chen, L., Gockley, A., Khoury-Collado, F., Hou, J., Clair, C. S. T., Melamed, A., Hershman, D. L., & Wright, J. D. (2023). Patterns of cervical cancer screening follow-up in the era of prolonged screening intervals. Gynecologic Oncology, 175, 53–59. https://doi.org/10.1016/j.ygyno.2023.06.007

Puram, S. V., Mints, M., Pal, A., Qi, Z., Reeb, A., Gelev, K., Barrett, T. F., Gerndt, S., Liu, P., Parikh, A. S., Ramadan, S., Law, T., Mroz, E. A., Rocco, J. W., Adkins, D., Thorstad, W. L., Gay, H. A., Ding, L., Paniello, R. C., … Tirosh, I. (2023). Cellular states are coupled to genomic and viral heterogeneity in HPV-related oropharyngeal carcinoma. Nature Genetics, 55(4), 640–650. https://doi.org/10.1038/s41588-023-01357-3

Silvera, S. A. N., Kaplan, A. M., & Laforet, P. (2022). Knowledge of Human Papillomavirus and Cervical Cancer Among Low-Income Women in New Jersey. Public Health Reports, 138(2), 302–308. https://doi.org/10.1177/00333549221081821

Li, D., Thomas, C., Shrivastava, N., Gersten, A., Gadsden, N., Schlecht, N., Kawachi, N., Schiff, B. A., Smith, R. V., Rosenblatt, G., Augustine, S., Gavathiotis, E., Burk, R., Prystowsky, M. B., Guha, C., Mehta, V., & Ow, T. J. (2023). Establishment of a diverse head and neck squamous cancer cell bank using conditional reprogramming culture methods. Journal of Medical Virology, 95(2). Portico. https://doi.org/10.1002/jmv.28388

Sannigrahi, M. K., Rajagopalan, P., Lai, L., Liu, X., Sahu, V., Nakagawa, H., Jalaly, J. B., Brody, R. M., Morgan, I. M., Windle, B. E., Wang, X., Gimotty, P. A., Kelly, D. P., White, E. A., & Basu, D. (2022). HPV E6 regulates therapy responses in oropharyngeal cancer by repressing the PGC-1α/ERRα axis. JCI Insight, 7(18). https://doi.org/10.1172/jci.insight.159600

Dinia, A., Ammari, S., Filtes, J., Classe, M., Moya-Plana, A., Bidault, F., Temam, S., Blanchard, P., Lassau, N., & Gorphe, P. (2022). Events prediction after treatment in HPV-driven oropharyngeal carcinoma using machine learning. European Journal of Cancer, 171, 106–113. https://doi.org/10.1016/j.ejca.2022.05.003

Liao, L., Chen, L., Gockley, A., Melamed, A., St Clair, C. M., Hou, J. Y., Khoury-Collado, F., Accordino, M., Hershman, D. L., & Wright, J. D. (2022). Temporal Trends in Cervical Cancer Screening Practices and Associated Downstream Abnormalities and Procedures Among Women With Insurance in the United States. Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000004838

Eng, C., Ciombor, K. K., Cho, M., Dorth, J. A., Rajdev, L. N., Horowitz, D. P., Gollub, M. J., Jácome, A. A., Lockney, N. A., Muldoon, R. L., Washington, M. K., O’Brian, B. A., Benny, A., Lebeck Lee, C. M., Benson, A. B., Goodman, K. A., & Morris, V. K. (2022). Anal Cancer: Emerging Standards in a Rare Disease. Journal of Clinical Oncology, 40(24), 2774–2788. https://doi.org/10.1200/jco.21.02566

Maruyama, Y., Sukegawa, A., Yoshida, H., Iwaizumi, Y., Nakagawa, S., Kino, T., Suzuki, Y., Kubota, K., Hirabuki, T., Mizushima, T., & Miyagi, E. (2022). Role of cervical cancer screening during prenatal checkups for infectious diseases: A retrospective, descriptive study. Journal of International Medical Research, 50(5). https://doi.org/10.1177/03000605221097488

Suzuki, Y., Sukegawa, A., Ueda, Y., Sekine, M., Enomoto, T., Melamed, A., Wright, J. D., & Miyagi, E. (2022). The Effect of a Web-Based Cervical Cancer Survivor’s Story on Parents’ Behavior and Willingness to Consider Human Papillomavirus Vaccination for Daughters: Randomized Controlled Trial. JMIR Public Health and Surveillance, 8(5), e34715. https://doi.org/10.2196/34715

Johnson, L. G., Saidu, R., Svanholm-Barrie, C., Boa, R., Moodley, J., Tergas, A., Persing, D., Campbell, S. A., Tsai, W.-Y., Wright, T. C., Denny, L., & Kuhn, L. (2022). Clinical Utility of Reflex Testing with Cancer Biomarkers to Improve Diagnostic Accuracy of Primary Human Papillomavirus Screening. Cancer Epidemiology, Biomarkers & Prevention, 31(3), 595–603. https://doi.org/10.1158/1055-9965.epi-21-0972